Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 22

1.

Sonographic assessment of interstitial lung disease in patients with rheumatoid arthritis, systemic sclerosis and systemic lupus erythematosus.

Moazedi-Fuerst F, Kielhauser S, Brickmann K, Tripolt N, Meilinger M, Lufti A, Graninger W.

Clin Exp Rheumatol. 2015 Jan 29. [Epub ahead of print]

PMID:
25665185
2.

Rituximab for systemic sclerosis: arrest of pulmonary disease progression in five cases. Results of a lower dosage and shorter interval regimen.

Moazedi-Fuerst FC, Kielhauser SM, Brickmann K, Hermann J, Lutfi A, Meilinger M, Brezinschek HP, Graninger WB.

Scand J Rheumatol. 2014;43(3):257-8. doi: 10.3109/03009742.2013.869617. Epub 2014 Mar 11. No abstract available.

3.

Response to: 'Paying attention to carpal tunnel contents lesions: ultrasound for evaluation of carpal tunnel syndrome' by zhu and Liu.

Dejaco C, Stradner M, Zauner D, Seel W, Simmet NE, Klammer A, Heitzer P, Brickmann K, Gretler J, Fürst-Moazedi F, Thonhofer R, Husic R, Hermann J, Graninger WB, Quasthoff S.

Ann Rheum Dis. 2014 Apr;73(4):e17. doi: 10.1136/annrheumdis-2013-205038. Epub 2014 Jan 9. No abstract available.

PMID:
24406545
4.

5-alkyl-1,3-oxazole derivatives of 6-amino-nicotinic acids as alkyl ester bioisosteres are antagonists of the P2Y12 receptor.

Bach P, Boström J, Brickmann K, Burgess LE, Clarke D, Groneberg RD, Harvey DM, Laird ER, O'Sullivan M, Zetterberg F.

Future Med Chem. 2013 Nov;5(17):2037-56. doi: 10.4155/fmc.13.171.

PMID:
24215345
5.

Synthesis, structure-property relationships and pharmacokinetic evaluation of ethyl 6-aminonicotinate sulfonylureas as antagonists of the P2Y₁₂ receptor.

Bach P, Boström J, Brickmann K, van Giezen JJ, Groneberg RD, Harvey DM, O'Sullivan M, Zetterberg F.

Eur J Med Chem. 2013 Jul;65:360-75. doi: 10.1016/j.ejmech.2013.04.007. Epub 2013 May 15.

PMID:
23747805
6.

Ultrasound for diagnosis of carpal tunnel syndrome: comparison of different methods to determine median nerve volume and value of power Doppler sonography.

Dejaco C, Stradner M, Zauner D, Seel W, Simmet NE, Klammer A, Heitzer P, Brickmann K, Gretler J, Fürst-Moazedi FC, Thonhofer R, Husic R, Hermann J, Graninger WB, Quasthoff S.

Ann Rheum Dis. 2013 Dec;72(12):1934-9. doi: 10.1136/annrheumdis-2012-202328. Epub 2012 Dec 4.

PMID:
23212030
7.

Pulmonary echography in systemic sclerosis.

Moazedi-Fuerst FC, Zechner PM, Tripolt NJ, Kielhauser SM, Brickmann K, Scheidl S, Lutfi A, Graninger WG.

Clin Rheumatol. 2012 Nov;31(11):1621-5. doi: 10.1007/s10067-012-2055-8. Epub 2012 Aug 18.

PMID:
22903701
8.

B lymphocyte-typing for prediction of clinical response to rituximab.

Brezinschek HP, Rainer F, Brickmann K, Graninger WB.

Arthritis Res Ther. 2012 Jul 6;14(4):R161. doi: 10.1186/ar3901.

9.

Design of small molecule inhibitors of acetyl-CoA carboxylase 1 and 2 showing reduction of hepatic malonyl-CoA levels in vivo in obese Zucker rats.

Bengtsson C, Blaho S, Saitton DB, Brickmann K, Broddefalk J, Davidsson O, Drmota T, Folmer R, Hallberg K, Hallén S, Hovland R, Isin E, Johannesson P, Kull B, Larsson LO, Löfgren L, Nilsson KE, Noeske T, Oakes N, Plowright AT, Schnecke V, Ståhlberg P, Sörme P, Wan H, Wellner E, Oster L.

Bioorg Med Chem. 2011 May 15;19(10):3039-53. doi: 10.1016/j.bmc.2011.04.014. Epub 2011 Apr 13.

PMID:
21515056
10.

A novel series of piperazinyl-pyridine ureas as antagonists of the purinergic P2Y12 receptor.

Bach P, Boström J, Brickmann K, van Giezen JJ, Hovland R, Petersson AU, Ray A, Zetterberg F.

Bioorg Med Chem Lett. 2011 May 15;21(10):2877-81. doi: 10.1016/j.bmcl.2011.03.088. Epub 2011 Mar 30.

PMID:
21507636
11.

Superior specificity of anti-citrullinated peptide antibodies in patients with chronic lymphocytic leukemia and arthritis.

Brickmann K, Brezinschek RI, Yazdani-Biuki B, Graninger WB, Brezinschek HP.

Clin Exp Rheumatol. 2010 Nov-Dec;28(6):888-91. Epub 2011 Jan 3.

PMID:
21205465
12.

The Stop Arthritis Very Early (SAVE) trial, an international multicentre, randomised, double-blind, placebo-controlled trial on glucocorticoids in very early arthritis.

Machold KP, Landewé R, Smolen JS, Stamm TA, van der Heijde DM, Verpoort KN, Brickmann K, Vázquez-Mellado J, Karateev DE, Breedveld FC, Emery P, Huizinga TW.

Ann Rheum Dis. 2010 Mar;69(3):495-502. doi: 10.1136/ard.2009.122473. Erratum in: Ann Rheum Dis. 2011 Aug;70(8):1519.

PMID:
20223838
13.

The functional promoter polymorphism of the coagulation factor XII gene is not associated with peripheral arterial disease.

Yazdani-Biuki B, Krippl P, Brickmann K, Fuerst F, Langsenlehner U, Paulweber B, Pilger E, Wascher TC, Brezinschek HP, Renner W.

Angiology. 2010 Feb;61(2):211-5. doi: 10.1177/0003319709337305. Epub 2009 Jul 21.

PMID:
19625260
14.

The Glu228Ala polymorphism in the ligand-binding domain of death receptor 4 is not associated with rheumatoid arthritis.

Yazdani-Biuki B, Brickmann K, Langsenlehner U, Renner W, Truschnig M, Krippl P, Fürst F, Graninger WB, Brezinschek HP.

Ann Rheum Dis. 2008 Jul;67(7):1053-4. doi: 10.1136/ard.2007.086124. No abstract available.

PMID:
18556450
15.

Design, synthesis and biological evaluation of thrombin inhibitors based on a pyridine scaffold.

Blomberg D, Fex T, Xue Y, Brickmann K, Kihlberg J.

Org Biomol Chem. 2007 Aug 21;5(16):2599-605.

PMID:
18019535
16.

The MHC2TA -168A>G gene polymorphism is not associated with rheumatoid arthritis in Austrian patients.

Yazdani-Biuki B, Brickmann K, Wohlfahrt K, Mueller T, März W, Renner W, Gutjahr M, Langsenlehner U, Krippl P, Wascher TC, Paulweber B, Graninger W, Brezinschek HP.

Arthritis Res Ther. 2006;8(4):R97.

17.

Treatment of rheumatoid arthritis in the 21st century: targeting B-lymphocytes.

Brezinschek HP, Brickmann K, Yazdani-Biuki B, Dörner T, Graninger WB, Brezinschek RI.

Wien Med Wochenschr. 2006 Jan;156(1-2):61-7. Review.

PMID:
16465615
18.

Synthesis and biological evaluation of leucine enkephalin turn mimetics.

Blomberg D, Kreye P, Fowler C, Brickmann K, Kihlberg J.

Org Biomol Chem. 2006 Feb 7;4(3):416-23. Epub 2006 Jan 9.

PMID:
16446799
19.

Blockade of tumour necrosis factor {alpha} significantly alters the serum level of IgG- and IgA-rheumatoid factor in patients with rheumatoid arthritis.

Yazdani-Biuki B, Stadlmaier E, Mulabecirovic A, Brezinschek R, Tilz G, Demel U, Mueller T, Brickmann K, Graninger WB, Brezinschek HP.

Ann Rheum Dis. 2005 Aug;64(8):1224-6.

20.

Synthesis and conformational studies of a beta-turn mimetic incorporated in Leu-enkephalin.

Blomberg D, Hedenström M, Kreye P, Sethson I, Brickmann K, Kihlberg J.

J Org Chem. 2004 May 14;69(10):3500-8.

PMID:
15132562
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Loading ...
Write to the Help Desk